1. Home
  2. CYBN vs EPSN Comparison

CYBN vs EPSN Comparison

Compare CYBN & EPSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYBN
  • EPSN
  • Stock Information
  • Founded
  • CYBN 2019
  • EPSN 2005
  • Country
  • CYBN Canada
  • EPSN Canada
  • Employees
  • CYBN N/A
  • EPSN N/A
  • Industry
  • CYBN Pharmaceuticals and Biotechnology
  • EPSN Oil & Gas Production
  • Sector
  • CYBN Health Care
  • EPSN Energy
  • Exchange
  • CYBN Nasdaq
  • EPSN Nasdaq
  • Market Cap
  • CYBN 178.7M
  • EPSN 175.3M
  • IPO Year
  • CYBN N/A
  • EPSN N/A
  • Fundamental
  • Price
  • CYBN $7.54
  • EPSN $6.10
  • Analyst Decision
  • CYBN Strong Buy
  • EPSN Strong Buy
  • Analyst Count
  • CYBN 4
  • EPSN 1
  • Target Price
  • CYBN $85.00
  • EPSN $7.00
  • AVG Volume (30 Days)
  • CYBN 412.3K
  • EPSN 129.4K
  • Earning Date
  • CYBN 08-12-2025
  • EPSN 08-13-2025
  • Dividend Yield
  • CYBN N/A
  • EPSN 4.10%
  • EPS Growth
  • CYBN N/A
  • EPSN N/A
  • EPS
  • CYBN N/A
  • EPSN 0.20
  • Revenue
  • CYBN N/A
  • EPSN $39,699,172.00
  • Revenue This Year
  • CYBN N/A
  • EPSN $41.35
  • Revenue Next Year
  • CYBN N/A
  • EPSN N/A
  • P/E Ratio
  • CYBN N/A
  • EPSN $31.09
  • Revenue Growth
  • CYBN N/A
  • EPSN 35.21
  • 52 Week Low
  • CYBN $4.81
  • EPSN $4.95
  • 52 Week High
  • CYBN $13.88
  • EPSN $8.50
  • Technical
  • Relative Strength Index (RSI)
  • CYBN 46.24
  • EPSN 30.69
  • Support Level
  • CYBN $7.26
  • EPSN $6.14
  • Resistance Level
  • CYBN $7.81
  • EPSN $6.47
  • Average True Range (ATR)
  • CYBN 0.45
  • EPSN 0.24
  • MACD
  • CYBN -0.04
  • EPSN -0.02
  • Stochastic Oscillator
  • CYBN 17.72
  • EPSN 4.59

About CYBN Cybin Inc.

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.

About EPSN Epsilon Energy Ltd. Common Share

Epsilon Energy Ltd is engaged in the acquisition, development, gathering, and production of natural gas and oil reserves. The operating segments of the company include Upstream segment activities including acquisition, development, and production of natural gas reserves on properties within the United States. The Gas Gathering segment partners with two other companies to operate a natural gas gathering system, and the corporate segment activities include corporate listing and governance functions of the corporation. The company generates revenue from the sale of crude oil and natural gas.

Share on Social Networks: